Copyright © 1999 by the European Society of Cardiology.
Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy
a Department of Internal Medicine II—Cardiology Section, Bielefeld Hospital, Academic Teaching Hospital of the University of Münster, Bielefeld, Germany
b Institute of Pathology, Bielefeld Hospital, Academic Teaching Hospital of the University of Münster, Bielefeld, Germany
revised January 8, 1999; accepted January 15, 1999
Abstract
Aims To evaluate acute and long-term symptomatic, haemodynamic (at rest and during exercise) and electrophysiological results of transcoronary ablation of septal hypertrophy (TASH), a catheter interventional treatment for hypertrophic obstructive cardiomyopathy.
Methods and Results Sixty-two transcoronary ablations of septal hypertrophy were performed by injection of 4·6±2·6ml 96% ethanol into septal branches in 50 patients with hypertrophic obstructive cardiomyopathy and severe symptoms. Serial left and right heart catheterization, transoesophageal echocardiography and electrophysiological investigations were repeated 2 weeks and 7±1 months (n=37) after intervention. Transcoronary ablation of septal hypertrophy led to a reduction in septal thickness, sustained elimination of the outflow obstruction (51±41 vs 6±10mmHg at rest, P<0·001; 134±48 vs 28±32mmHg, P<0·001, post-extrasystolic), a decrease in left ventricular filling pressures at rest and during exercise and a pronounced clinical improvement. There was no evidence for the creation of an arrhythmogenic substrate as assessed by serial programmed electrical stimulation in 39 patients. However, permanent high-grade atrioventricular block occurred in 17% of the patients. There were two early, but no late deaths during a mean follow-up time of 10·6±5·6 months.
Conclusion Transcoronary ablation of septal hypertrophy is a promising new treatment for hypertrophic obstructive cardiomyopathy in patients with severe symptoms. It should now be compared with alternative treatment strategies in prospective randomized studies.
Key Words: Therapy of hypertrophic obstructive cardiomyopathy, catheter interventional therapy, cardiac hypertrophy, effect of ethanol
f1 Correspondence : Dr Frank H. Gietzen, Medizinische Klinik II, Staedtische Kliniken Bielefeld-Mitte, Teutoburgerstr. 50, D-33604 Bielefeld, Germany.
References
- Loogen F, Kuhn H, Gietzen F, Lösse B, Schulte D, Birks W. Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy. Eur Heart J. 1983;4:145–153
- Kuhn H, Gietzen F, Mercier J. Studies of the clinical picture, course, and prognosis of different forms of hypertrophic cardiomyopathy. Z Kardiol. 1983;72:83–98[Web of Science][Medline]
- Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 1987;316:780–789[Web of Science][Medline]
- Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation. 1995;92:1680–1692
[Free Full Text] - Spirito P, Seidman CE, McKenna WJ, Maron BJ. Medical progress: The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775–785
[Free Full Text] - Haberer T, Hess OM, Jenni R, Krayenbühl HP. Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propanolol and verapamil. Z Kardiol. 1983;72:487–493[Web of Science][Medline]
- Rosing DR, Condit JR, Maron BJ. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. Am J Cardiol. 1981;48:545–553[CrossRef][Web of Science][Medline]
- Maron BJ, Epstein SE, Morrow AG. Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy. Eur Heart J. 1983;4:175–185
- Schulte HD, Gramsch-Zabel H, Schwartzkopff R. Hypertrophic obstructive cardiomyopathy (HOCM): surgical management. Schweiz Med Wochenschr. 1995;125:1940–1949[Web of Science][Medline]
- Schoendube FA, Klues HG, Reith S, Flachskampf FA, Hanrath P, Messmer BJ. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation. 1995;92:II-122–31
- McIntosh CL, Maron BJ, Cannon RO III, Klues HG. Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Circulation. 1992;86:II-60–7
- Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber pacing in obstructive hypertrophic cardiomyopathy. Circulation. 1994;90:2731–2742
[Abstract/Free Full Text] - Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet. 1992;339:1318–1323[CrossRef][Web of Science][Medline]
- Kappenberger L, Linde C, Daubert C. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J. 1997;18:1249–1256
[Abstract/Free Full Text] - Nishimura RA, Trusty JM, Hayes DL. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial. J Am Coll Cardiol. 1997;29:435–441[Abstract]
- Strunk-Mueller C, Gietzen F, Kuhn H. Unchanged hemodynamics in DDD pacemaker stimulation because of hypertrophic cardiomyopathy in subjective clinical improvement (Abstr). Eur Heart J. 1996;17:170
[Free Full Text] - Gietzen F, Leuner Ch, Gerenkamp Th, Kuhn H. Relief of obstruction in hypertrophic cardiomyopathy by transient occlusion of the first septal branch of the left coronary artery (Abstr). Eur Heart J. 1994;15:125
[Abstract/Free Full Text] - Kuhn H, Gietzen F, Leuner Ch, Gerenkamp Th. Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy: studies to develop a new catheter-based concept of treatment. Eur Heart J. 1997;18:846–851
[Abstract/Free Full Text] - Inoue H, Waller BF, Zipes DP. Intracoronary ethylalcohol or phenol injection ablates aconitine-induced ventricular tachycardia in dogs. J Am Coll Cardiol. 1987;10:1342–1349[Abstract]
- Haines DE, Whayne JG, Di Marco JP. Intracoronary ethanol ablation in Swine: Effects of ethanol concentration on lesion formation and response to programmed ventricular stimulation. J Cardiovasc Electrophysiol. 1994;5:422–431[Web of Science][Medline]
- Brugada P, de Swart HB, Bär FWHM, Smeets JLRM, van Ommen V, Wellens HJJ. Transcoronary termination and chemical ablation of arrhythmias. Zipes DP, Jalife J. Cardiac Electrophysiology—From Cell to Bedside. Philadelphia: Saunders; 1990. p. 1005–1014
- Kay GN, Epstein AE, Bubien RS, Anderson PG, Daily SM, Plumb VJ. Intracoronary ethanol ablation for the treatment of recurrent sustained ventricular tachycardia. J Am Coll Cardiol. 1992;19:159–168[Abstract]
- Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211–214[CrossRef][Web of Science][Medline]
- Gietzen F, Leuner Ch, Gerenkamp Th, Kuhn H. Katheterinterventionelle Therapie der hypertrophisch obstruktiven Kardiomyopathie durch Alkoholablation des ersten Septalastes der linken Koronararterie (Abstr). Z. Kardiol. 1996;85:3
- Gleichmann U, Seggewiß H, Faber L, Faßbender D, Schmidt HK, Strick S. Kathetertherapie der hypertrophen obstruktiven Kardiomyopathie. Dtsch med Wschr. 1996;121:679–685[Medline]
- Knight Ch, Kurbaan AS, Seggewiss H. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy. Outcome in the first series of patients. Circulation. 1997;95:2075–2081
[Abstract/Free Full Text] - Lakkis N, Kleiman N, Killip D, Spencer WH III. Hypertrophic obstructive cardiomyopathy: alternative therapeutic options. Clin Cardiol. 1997;20:417–418[Web of Science][Medline]
- Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol. 1998;31:252–258
[Abstract/Free Full Text] - Faber L, Seggewiß H, Strick S, Bogunovic N, Gleichmann U. Intra-procedural myocardial contrast echocardiography: a routine procedure in percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy (Abstr). Eur Heart J. 1998;19:12[Web of Science][Medline]
- Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072–1083
[Abstract/Free Full Text] - Gilbert BW, Pollick C, Adelman AG, Wigle ED. Hypertrophic cardiomyopathy: subclassification by M-mode echocardiography. Am J Cardiol. 1980;45:861–872[CrossRef][Web of Science][Medline]
- Sellers RD, Levy MJ, Amplatz K, Lillehei CW. Left retrograde cardioangiography in acquired cardiac disease. Technic, indications and interpretations in 700 cases. Am J Cardiol. 1964;14:437–447[CrossRef][Web of Science][Medline]
- Lösse B, Loogen F, Schulte HD. Hemodynamic longterm results after medical and surgical therapy of hypertrophic cardiomyopathies. Z Kardiol. 1987;76:119–130
- Denniss AR, Richards DA, Cody DV. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation. 1986;74:731–745
[Abstract/Free Full Text] - Maron BJ, Merrill WH, Freier PA, Kent KM, Epstein SE, Morrow AG. Long term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation. 1978;57:1205–1213
[Abstract/Free Full Text] - Borggrefe, M, Ergebnisse zur Hochfrequenzstromablation der atrioventriculären Überleitung, Borggrefe, M, Steinkopff Darmstadt, 1994, 58, 61
- McAreavey D, Fananapazir L. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy. Am J Cardiol. 1992;70:651–656[CrossRef][Web of Science][Medline]
- Gietzen FH, Kuhn H, Leuner ChJ, Hegselmann J, Strunk-Mueller C. Acute and long-term results after transcoronary ablation of septum hypertrophy by selective septal branch injection of ethanol. A catheter interventional treatment for hypertrophic obstructive cardiomyopathy (Abstr). Circulation. 1998;98:I–86
- Braunwald E. A new treatment for hypertrophic cardiomyopathy? Eur Heart J. 1997;18:709–710
[Free Full Text] - Braunwald E. Induced septal infarction. A new therapeutic strategy for hypertrophic obstructive cardiomyopathy. Circulation. 1997;95:1981–1982
[Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. K. Dhar, V. Varadharajan, A. Al-Mohammad, J. Sandoval, and E. D Grech Symptomatic hypertrophic obstructive cardiomyopathy: semi-supine bicycle ergometry as a useful provocative manoeuvre to elicit latent gradient BMJ Case Reports, March 30, 2009; 2009(mar30_1): bcr1020081044 - bcr1020081044. [Abstract] [Full Text]
|
|
|
|
 |
|
 G S Soor, A Luk, E Ahn, J R Abraham, A Woo, A Ralph-Edwards, and J Butany Hypertrophic cardiomyopathy: current understanding and treatment objectives J. Clin. Pathol., March 1, 2009; 62(3): 226 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Cuoco, W. H. Spencer III, V. L. Fernandes, C. D. Nielsen, S. Nagueh, J. L. Sturdivant, R. B. Leman, J. M. Wharton, and M. R. Gold Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Death After Alcohol Septal Ablation of Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., November 18, 2008; 52(21): 1718 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Malek, L. Chojnowska, M. Klopotowski, R. Maczynska, M. Demkow, A. Witkowski, B. Kusmierczyk, E. Piotrowicz, M. Konka, M. Dabrowski, et al. Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation Eur J Heart Fail, November 1, 2008; 10(11): 1123 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Fernandes, C. Nielsen, S. F. Nagueh, A. E. Herrin, C. Slifka, J. Franklin, and W. H. Spencer III Follow-Up of Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy: The Baylor and Medical University of South Carolina Experience 1996 to 2007 J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 561 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Kwon, S. R. Kapadia, E. M. Tuzcu, C. M. Halley, E. Z. Gorodeski, R. J. Curtin, M. Thamilarasan, N. G. Smedira, B. W. Lytle, H. M. Lever, et al. Long-Term Outcomes in High-Risk Symptomatic Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Mittnacht, M. Fanshawe, and S. Konstadt Anesthetic Considerations in the Patient With Valvular Heart Disease Undergoing Noncardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2008; 12(1): 33 - 59. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Durand, E. Mousseaux, P. Coste, R. Pilliere, O. Dubourg, L. Trinquart, G. Chatellier, A. Hagege, M. Desnos, and A. Lafont Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up Eur. Heart J., February 1, 2008; 29(3): 348 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Fifer and G. J. Vlahakes Management of Symptoms in Hypertrophic Cardiomyopathy Circulation, January 22, 2008; 117(3): 429 - 439. [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Hansen and N. Merchant MRI of Hypertrophic Cardiomyopathy: Part 2, Differential Diagnosis, Risk Stratification, and Posttreatment MRI Appearances Am. J. Roentgenol., December 1, 2007; 189(6): 1344 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Maron Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy Circulation, July 10, 2007; 116(2): 196 - 206. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Fifer Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy Circulation, July 10, 2007; 116(2): 207 - 216. [Full Text] [PDF]
|
|
|
|
|
|
T. Lawrenz, F. Lieder, M. Bartelsmeier, C. Leuner, B. Borchert, D. Meyer zu Vilsendorf, C. Strunk-Mueller, J. Reinhardt, A. Feuchtl, C. Stellbrink, et al. Predictors of Complete Heart Block After Transcoronary Ablation of Septal Hypertrophy: Results of a Prospective Electrophysiological Investigation in 172 Patients With Hypertrophic Obstructive Cardiomyopathy J. Am. Coll. Cardiol., June 19, 2007; 49(24): 2356 - 2363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Heldman, K. C. Wu, T. P. Abraham, and D. E. Cameron Myectomy or Alcohol Septal Ablation: Surgery and Percutaneous Intervention Go Another Round J. Am. Coll. Cardiol., January 23, 2007; 49(3): 358 - 360. [Full Text] [PDF]
|
|
|
|
 |
|
 A L Baggish, R N Smith, I Palacios, G J Vlahakes, D M Yoerger, M H Picard, P A Lowry, I-k Jang, and M A Fifer Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy Heart, December 1, 2006; 92(12): 1773 - 1778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Jassal, T. G. Neilan, M. A. Fifer, I. F. Palacios, P. A. Lowry, G. J. Vlahakes, M. H. Picard, and D. M. Yoerger Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy Eur. Heart J., August 1, 2006; 27(15): 1805 - 1810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. van der Lee, F. J. ten Cate, M. L. Geleijnse, M. J. Kofflard, C. Pedone, L. A. van Herwerden, E. Biagini, W. B. Vletter, and P. W. Serruys Percutaneous Versus Surgical Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy and Enlarged Anterior Mitral Valve Leaflets Circulation, July 26, 2005; 112(4): 482 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Roberts and U. Sigwart Current Concepts of the Pathogenesis and Treatment of Hypertrophic Cardiomyopathy Circulation, July 12, 2005; 112(2): 293 - 296. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hering, D. Welge, D. Fassbender, D. Horstkotte, and L. Faber Quantitative analysis of intraprocedural myocardial contrast echocardiography during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy Eur J Echocardiogr, December 1, 2004; 5(6): 443 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Maron, J. A. Dearani, S. R. Ommen, M. S. Maron, H. V. Schaff, B. J. Gersh, and R. A. Nishimura The case for surgery in obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2044 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Faber, H. Seggewiss, D. Welge, D. Fassbender, H. K. Schmidt, U. Gleichmann, and D. Horstkotte Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience Eur J Echocardiogr, October 1, 2004; 5(5): 347 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F H Gietzen, C J Leuner, L Obergassel, C Strunk-Mueller, and H Kuhn Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients Heart, June 1, 2004; 90(6): 638 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Amano, M. Takayama, M. Amano, and T. Kumazaki MRI of Cardiac Morphology and Function After Percutaneous Transluminal Septal Myocardial Ablation for Hypertrophic Obstructive Cardiomyopathy Am. J. Roentgenol., February 1, 2004; 182(2): 523 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713. [Full Text] [PDF]
|
|
|
|
|
|
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991. [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Sherrid, F. A. Chaudhry, and D. G. Swistel Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction Ann. Thorac. Surg., February 1, 2003; 75(2): 620 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Gietzen, C. J. Leuner, L. Obergassel, C. Strunk-Mueller, and H. Kuhn Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions Circulation, July 23, 2002; 106(4): 454 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xin, T. Shiota, H. M. Lever, S. R. Kapadia, M. Sitges, D. N. Rubin, F. Bauer, N. L. Greenberg, D. A. Agler, J. K. Drinko, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1994 - 2000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Wigle, L. Schwartz, A. Woo, and H. Rakowski To ablate or operate? that is the question! J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1707 - 1710. [Full Text] [PDF]
|
|
|
|
|
|
R. Roberts and U. Sigwart New Concepts in Hypertrophic Cardiomyopathies, Part II Circulation, October 30, 2001; 104(18): 2249 - 2252. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Sigwart Non-surgical myocardial reduction for patients with hypertrophic obstructive cardiomyopathy Eur. Heart J. Suppl., October 1, 2001; 3(suppl_L): L38 - L42. [Abstract] [PDF]
|
|
|
|
|
|
P. Boekstegers, P. Steinbigler, A. Molnar, M. Schwaiblmair, A. Becker, A. Knez, R. Haberl, and G. Steinbeck Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy J. Am. Coll. Cardiol., September 1, 2001; 38(3): 846 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Seggewiss Percutaneous transluminal septal myocardial ablation: A new treatment for hypertrophic obstructive cardiomyopathy Eur. Heart J., May 1, 2000; 21(9): 704 - 707. [PDF]
|
|
|
|
|
|
L. Faber Acute and long-term results after TASH Eur. Heart J., April 1, 2000; 21(7): 590 - 591. [PDF]
|
|
|
|
|
|
F.H. Gietzen, CH.J. Leuner, J. Hegselmann, C. Strunk-Mueller, and H. Khun A reply Eur. Heart J., April 1, 2000; 21(7): 591 - 593. [PDF]
|
|
|
|
|
|
C. J KNIGHT Five years of percutaneous transluminal septal myocardial ablation Heart, March 1, 2000; 83(3): 255 - 256. [Full Text]
|
|
|
|
|
|
H. Kuhn, F.H. Gietzen, M. Schafers, M. Freick, B. Gockel, C. Strunk-Muller, E. Jachmann, and O. Schober Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion Eur. Heart J., December 2, 1999; 20(24): 1808 - 1817. [Abstract] [PDF]
|
|
|
|
|
|
B.J. Maron New interventions for obstructive hypertrophic cardiomyopathy: promise and prudence Eur. Heart J., September 2, 1999; 20(18): 1292 - 1294. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||